Pfizer (PFE) 10-Q2014 Q1 Quarterly report

Filed: 8 May 14, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: absolute, arm, Beijing, Bolivia, Breakthrough, Calcium, Cangialosi, CAP, Capsugel, Carolina, CENCOEX, Chairman, Chemistry, Chile, clarified, Colombia, competing, concept, constant, consummate, consummating, consumption, contacted, crystalline, daily, deep, disaggregate, Divestiture, dramatic, duly, DVT, economy, enjoined, ER, esomeprazole, extreme, Frank, gastric, grew, ground, Guatemala, headcount, holistic, hyperinflationary, Ian, ibuprofen, incidence, interference, Lankler, led, letrozole, long, Loretta, matrix, mg, MnB, naproxen, necessarily, Nicorette, Nonfunded, overridden, palbociclib, PCS, PE, pence, PRECISION, preferential, President, proof, properly, proportional, Proxy, quickly, randomized, rapidly, Ratio, Ratiopharm, realignment, reallocated, recall, reconciling, redeploy, registrant, render, rendered, renew, retailer, retrial, revaluation, secondary, sequester, SFJ, SGR, shown, SICAD, skin, smaller, SPC, spite, statistically, sterile, survival, Taiwan, thereunder, thereunto, Torrent, Trastuzumab, undergone, undersigned, Uruguay, user, vein, Venezuela, venture, Vice, virtue, waived, weather, WRD

Removed: Aberdeen, accelerate, acceptance, Activella, Ad, added, addressing, adjudicated, adversely, advertised, Advil, Aetna, AF, affiliate, affiliated, Alacer, amending, analog, apparent, appointed, Aromasin, arrangement, Arthrotec, assessing, attention, authentic, autism, autoimmune, automatic, Aygestin, balloting, begun, BI, Biocon, bladder, borrowing, Bosulif, Brigham, building, Caduet, Caltrate, capsule, capture, cast, Catania, Centrum, certify, ChapStick, charged, chemotherapy, child, childhood, Chinese, classified, closing, collaboratively, combat, complexity, comprising, conclusion, conducting, confirmation, consortium, constituting, contested, copy, cotransporter, counteract, counterfeiting, crime, curtailment, Cycrin, Danish, deceptive, declaratory, deficit, deliberately, delivered, denying, dietary, directing, discontinuation, disguising, disposed, disputed, distinguish, distributed, divestment, documentation, drink, dust, ease, easier, effervescent, Eisai, EMD, enabling, endocrine, ertugliflozin, establishment, Estring, evade, evenly, evolve, exacerbated, excellence, excise, exempt, exited, expensive, exploring, faced, facilitate, facilitated, FASB, femhrt, Ferrosan, footprint, freeze, fundamental, genitourinary, Geodon, glucose, Gosport, govern, Governor, graduated, greatly, growing, heard, hearing, heart, highlight, hinder, history, Hoc, hyperactivity, identifying, identity, implement, inability, inception, inflammatory, initiative, injunction, injured, installment, institutional, insulin, interaction, internet, interpretation, Inventia, involvement, ischemic, Januvia, Kaiser, lack, lawsuit, lease, leave, lifestyle, Likewise, litigated, malignant, manager, margin, marketed, maturity, medication, medicinal, medicine, Medrol, mental, metformin, methylphenidate, migrating, minimal, mislabeled, Missouri, mitigate, mixed, MMR, MO, modest, move, MPA, multinational, mutual, Mylotarg, negotiated, Nestl, Nevada, NextWave, Nordic, Nordisk, Northern, notice, Novo, Nycomed, occasionally, Ogen, OMB, ophthalmology, opportunistic, opt, optimize, orderly, organizational, orthopedic, ovarian, overactive, overallotment, perpetuity, petitioner, Philadelphia, point, policy, pose, potentially, powdered, Premphase, Prempro, prenatal, presently, preservative, preserve, prevailed, prevalence, prioritizing, privately, procedural, procured, profit, profitable, progestin, prohibited, prohibiting, promoting, promotional, proportionate, prosecute, Provera, Quigley, Quillivant, rationalized, recommending, refractory, refund, regimen, registered, Relpax, renminbi, reportable, requisite, resistant, retain, reversal, rheumatology, Robitussin, rubella, ruling, Sandwich, scale, schedule, scheduled, separate, Serono, shifted, Shionogi, silica, sitagliptin, smoking, Social, sodium, solicit, sophisticated, spectrum, St, standardize, step, streamlined, subsidy, suffer, Sun, supporting, surveillance, suspend, tablet, tabulation, terminal, terminate, test, theory, thimerosal, threat, thromboembolism, TKI, TNF, Torisel, toxicology, transport, trebled, trend, trillion, true, UK, unchanged, uninspected, Union, University, unlicensed, unpaid, unregulated, unresolved, unsanitary, unsettled, upholding, utilizing, vacant, Vagifem, Veteran, Vfend, viii, violate, vitamin, Vyndaqel, weakening, widespread, Xalacom, Xalatan, Xyntha, Zosyn

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

PFE similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 15

Accountants' Acknowledgment

To the Board of Directors and the Shareholders of Pfizer Inc.:

We hereby acknowledge our awareness of the use therein of our report dated May 8, 2014, included within the Quarterly Report on Form 10-Q of Pfizer Inc. for the quarter ended March 30, 2014, in the following Registration Statements:

-Form S-8 dated October 27, 1983 (File No. 2-87473),

-Form S-8 dated March 22, 1990 (File No. 33-34139),

-Form S-8 dated January 24, 1991 (File No. 33-38708),

-Form S-8 dated November 18, 1991 (File No. 33-44053),

-Form S-8 dated May 27, 1993 (File No. 33-49631),

-Form S-8 dated May 19, 1994 (File No. 33-53713),

-Form S-8 dated October 5, 1994 (File No. 33-55771),

-Form S-8 dated December 20, 1994 (File No. 33-56979),

-Form S-8 dated March 29, 1996 (File No. 33-02061),

-Form S-8 dated September 25, 1997 (File No. 333-36371),

-Form S-8 dated April 24, 1998 (File No. 333-50899),

-Form S-8 dated April 22, 1999 (File No. 333-76839),

-Form S-8 dated June 19, 2000 (File No. 333-39610),

-Form S-8 dated April 27, 2001 (File No. 333-59660),

-Form S-8 dated April 27, 2001 (File No. 333-59654),

-Form S-8 dated April 16, 2003 (File No. 333-104581),

-Form S-8 dated April 16, 2003 (File No. 333-104582),

-Form S-8 dated November 18, 2003 (File No. 333-110571),

-Form S-8 dated December 18, 2003 (File No. 333-111333),

-Form S-8 dated April 26, 2004 (File No. 333-114852),

-Form S-8 dated March 1, 2007 (File No. 333-140987),

-Form S-4 dated March 27, 2009 (File No. 333-158237),

-Form S-8 dated October 16, 2009 (File No. 333-162519),

-Form S-8 dated October 16, 2009 (File No. 333-162520),

-Form S-8 dated October 16, 2009 (File No. 333-162521),

-Form S-8 dated March 1, 2010 (File No. 333-165121) and

-Form S-3 dated May 10, 2012 (File No. 333-181321).

Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered a part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.

/s/KPMG LLP

New York, New York

May 8, 2014